CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. It comprises CSL Behring, CSL Seqirus, and CSL Vifor, providing diverse offerings to ensure patients and people everywhere get the treatments they need.

Marsden Eye Specialists is involved in eye surgery and the treatment of various eye conditions such as cataracts, glaucoma, and retinal diseases. It also offers laser vision correction services.

Marsden Eye Specialists

Switzerland Innovation Park Basel Area provides ready-made and customizable workspaces for various teams, focusing on innovation in healthcare, life sciences, and technology.

Switzerland Innovation Park Basel Area

CSL Plasma

CSL Vifor

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.

Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

See our community guidelines: https://bit.ly/3Bs17Ra

CEO and Managing Director Paul McKenzie speaks to the outlook for CSL.  A recording of the half year earnings webcast can be found at our investor center:  https://bit.ly/48vgIhb #CSL 

CSL's CEO and Managing Director Paul McKenzie summarizes our financial performance for the first half of FY2024.  More: https://bit.ly/42EUzvj 

We have just released our half year results for financial year 2024. Check out a snapshot below, or head to our investor center for more information. https://bit.ly/4bAsSaX 

CSL’s Head of Research & Development, Dr. Bill Mezzanotte, weighs in on how the AEGIS-II program has left a lasting impact on our organization. Read more: https://bit.ly/49zh3Aj 

Today, we announced top-line results from the Phase 3 AEGIS-II trial. Read more: https://bit.ly/3I0ZVaA #CSL

Today, on the International Day of Women and Girls in Science, we uplift and celebrate the phenomenal women and girls who innovate, discover and inspire in the field of science!  Your pursuits push boundaries and forge a future in which every dream is possible.

Explore career opportunities at CSL: https://bit.ly/42QWopj

#InternationalDayOfWomenAndGirlsInScience #PromisingFutures #CSL


Metric
Company Name	CSL	Marsden Eye Specialists	Switzerland Innovation Park Basel Area
Symbol
MSH ID	COM:CSL	AU:COM:MARSDENEYE	COM:SIP-BASELAREA
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services
Industry	Biotechnology and Pharmaceuticals	Healthcare	Real Estate
Country	AU	AU	CH
Stage
Employee Count	20.94K
Website	csl.com	marsdeneye.com.au	sip-baselarea.com
LinkedIn	csl		switzerland-innovation-park-basel-area
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	45.33
28-Day Growth Score	50.58
90-Day Growth Score	48.65
365-Day Growth Score	46.71

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CSL

CSL

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue